This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Companies Getting Ready to Hike Dividends in 2013

Johnson & Johnson

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

You won't find a better core income holding than Johnson & Johnson (JNJ). The $202 billion healthcare stock has its hands in everything from consumer products like Band-Aid brand bandages to pharmaceuticals and medical devices.

That diversification provides some big benefits for JNJ -- and it helps provide some big dividend payouts as well. As I write, Johnson & Johnson pays a 61-cent quarterly dividend for a 3.33% yield. I think that number is likely to get hiked in the next quarter.

>>5 Big Consumer Stocks to Buy on the Cheap

Johnson & Johnson carries the huge profitability of a pharmaceutical company without all of the risks of big patent drop-offs looming on the horizon. Note that I said all the risks; JNJ certainly carries some of them. This year, the firm is set to lose patent protection of a couple of important drugs. That said, the effects of the patent losses should be mitigated by strength elsewhere in JNJ's business, especially in demand tailwinds that are only just starting to pick up for investors.

Another big draw for Johnson & Johnson is cash. The firm has around $20 billion of it before its $16.8 billion of debt is accounted for, and even then JNJ is better capitalized than most peers. This firm earns enormous free cash flows each year, and now, with major acquisitions behind it, management will be able to deploy more of that cash for dividends.

As of the most recently reported quarter, J&J was one of George Soros' top holdings and also showed up in Bridgewater Associates' portfolio.

2 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,139.48 -33.20 -0.19%
S&P 500 1,994.12 -0.17 -0.01%
NASDAQ 4,533.1750 +5.4860 0.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs